Skip to main content
ICRweb
About Issuing Certificates

ICR Contents

Regulatory Guidelines
All Contents
  • Fresh Insights Playlist
    • [Part 1] Opening Remarks and Introduction of ATLAS: Malignancy in People Living with HIV
    • [Part 2] HIV associated malignancies: Malignancy in People Living with HIV
    • [Part 3] HIV and Malignancies: Challenges in Diagnosis and Management: Malignancy in People Living with HIV
    • [Part 4] Discussion : Malignancy in People Living with HIV
    • [Part 1] Opening Remarks and Introduction of ATLAS: Lung Cancer
    • [Part 2] Recent advance in treatment for early-stage non-small cell lung cancer: Lung Cancer
    • [Part 3] Lung Cancer screening program utilizing CT scans in South Korea: Lung Cancer
    • [Part 4]Discussion: Lung Cancer
  • Fresh Insights Playlist
    • [Part 1] Opening Remarks and Introduction of ATLAS: Malignancy in People Living with HIV
    • [Part 2] HIV associated malignancies: Malignancy in People Living with HIV
    • [Part 3] HIV and Malignancies: Challenges in Diagnosis and Management: Malignancy in People Living with HIV
    • [Part 4] Discussion : Malignancy in People Living with HIV
    • [Part 1] Opening Remarks and Introduction of ATLAS: Lung Cancer
    • [Part 2] Recent advance in treatment for early-stage non-small cell lung cancer: Lung Cancer
    • [Part 3] Lung Cancer screening program utilizing CT scans in South Korea: Lung Cancer
    • [Part 4]Discussion: Lung Cancer
  • Recommended Lectures
    • Cancer Biology and Molecular Biology
    • Sample handling
    • Procedures and Interpretation of Next Generation Sequencing Results
    • Methods of utilizing NGS test results (off-label, clinical trial, etc.)
    • ISO 15189 accreditation program for molecular-genetic laboratories
    • Basic Knowledge and Practical Consideration of Phase I Trials in Oncology
    • The General Role Of CRCs In Cancer Clinical Trials
    • Review of cancer clinical trial protocols from a CRC perspective
    • Minimum statistical knowledge required for clinical trials on cancer - Part 1 of 2
    • Designs for clinical trials on cancer - Part 1 of 2
What is ICRweb? What is ATLAS? FAQ Contact

Visitor Counter

ICRweb
  • About ICRweb
  • What is ATLAS?
  • FAQ
  • Contact
  • Japanese
  • Log in
    Sign up

ICRweb: Introduction to Clinical Research (Guest)

Request for Updating your profile
due to site renewal

Thank you for using Introduction to Clinical Research (ICRweb) e-learning site. Please update your profile in order to improve our service to provide better lectures and information that you need.
Time required: Approximately 1 to 2 min.
Update your profile Later....

  • Cancer Genomic Medicine: Essential Course

    ATLAS (Asian clinical TriaLs network for cAncerS) project - Training Program
    Cancer Genomic Medicine Course
    Target trainees: Physicians, laboratory technicians and other relevant professionals who engage or would like to engage cancer genome-based medicine.

    • ATLAS PROJECT
    • The Mission of ATLAS [National Cancer Center Japan Hospital] - YouTube
    • ATLAS project | Facebook
Skip Latest announcements
Latest announcements
  • 12 Nov 2024
    Four new lectures added in "ATLAS Monthly Webinar"
  • 24 Sep 2024
    Four new lectures added in “ATLAS Monthly Webinar”
  • 10 Sep 2024
    A new course “ATLAS Monthly Webinar” launched
  • 20 Feb 2024
    A new lecture entitled “ISO 15189 Clinical Laboratory Accreditation - Accreditation of gene-related testing -” is available.
  • 30 Jan 2024
    A new course “Outline of Clinical Trials on Cancer” with 6 videos has become available.
Older topics ...
Skip Fresh Insights Playlist
Fresh Insights Playlist

  • Embark on a learning adventure with our "Fresh Insights Playlist," a curated collection of the latest lectures that promise to spark curiosity and elevate your educational journey. Stay tuned for a dynamic blend of cutting-edge content designed to keep you at the forefront of knowledge.

    • 00:05:54

      [Part 1] Opening Remarks and Introduction of ATLAS: Malignancy in People Living with HIV

      [Topic] Malignancy in People Living with HIV[Date] 14 Oct 2024 [Part 1] Opening Remarks and Introduction of ATLAS[Opening Remarks]　Dr. Marcelo Severino B. Imasa(St. Luke’s Medical Center, Philippines)[Introduction of ATLAS]Dr. Yuta Sekino(National Cancer Center Hospital, Japan)

      Views6

      User evaluation

      Updated on：2024/10/14

    • 00:31:18

      [Part 2] HIV associated malignancies: Malignancy in People Living with HIV

      [Topic] Malignancy in People Living with HIV[Date] 14 Oct 2024[Part2] Lecture1: HIV associated malignancies[Speaker]　Dr. Jay T. Datukan(St. Luke’s Medical Center, Philippines)

      Views2

      User evaluation

      Updated on：2024/10/14

    • 00:27:28

      [Part 3] HIV and Malignancies: Challenges in Diagnosis and Management: Malignancy in People Living with HIV

      [Topic] Malignancy in People Living with HIV[Date] 14 Oct 2024[Part 3] Lecture2: HIV and Malignancies: Challenges in Diagnosis and Management[Speaker]Dr. Gelza Mae Zabat(St. Luke’s Medical Center, Philippines)

      Views1

      User evaluation

      Updated on：2024/10/14

    • 00:16:36

      [Part 4] Discussion : Malignancy in People Living with HIV

      [Topic] Malignancy in People Living with HIV[Date] 14 Oct 2024[Part 4] Disscusion[Facilitator] Dr. Jose Jasper Andal(St. Luke’s Medical Center, Philippines) [Participants]Dr. Jay T. Datukan(St. Luke’s Medical Center, Philippines)Dr. Gelza Mae Zabat(St. Luke’s Medical Center, Philippines)

      Views1

      User evaluation

      Updated on：2024/10/14

    • 00:10:04

      [Part 1] Opening Remarks and Introduction of ATLAS: Lung Cancer

      [Topic] Lung Cancer[Date]26 Aug 2024 [Part 1] Opening Remarks and Introduction of ATLAS[Speaker]　Dr. Yuta Sekino(National Cancer Center Hospital, Japan)

      Views8

      User evaluation

      Updated on：2024/8/26

    • 00:20:47

      [Part 2] Recent advance in treatment for early-stage non-small cell lung cancer: Lung Cancer

      [Topic] Lung Cancer[Date]26 Aug 2024 [Part2] Lecture1: Recent advance in treatment for early-stage non-small cell lung cancer[Speaker]　Dr. Hidehito Horinouchi(Department of Thoracic Oncology, National Cancer Center Hospital, Japan)

      Views14

      User evaluation

      Updated on：2024/8/26

    • 00:22:07

      [Part 3] Lung Cancer screening program utilizing CT scans in South Korea: Lung Cancer

      [Topic] Lung Cancer[Date]26 Aug 2024[Part 3] Lecture2: Lung Cancer screening program utilizing CT scans in South Korea: Lung Cancer [Speaker]Dr. Yeon Wook Kim(Department of Internal Medicine Seoul National University Bundang Hospital, South Korea)Please note: Due to technical issues during recording, portions of this video may experience audio and visual distortions. We apologize for any inconvenience and thank you for your understanding.

      Views5

      User evaluation

      Updated on：2024/8/26

    • 00:16:37

      [Part 4]Discussion: Lung Cancer

      [Topic] Lung Cancer[Date]26 Aug 2024 [Part 4] Discussion [Facilitator]Dr. Hidehito Horinouchi(Department of Thoracic Oncology, National Cancer Center Hospital, Japan)[Participants]Dr. Yeon Wook Kim(Department of Internal Medicine Seoul National University Bundang Hospital, South Korea)

      Views6

      User evaluation

      Updated on：2024/8/26
    ‹
    ›
Skip Recommended Lectures
Recommended Lectures

  • The recommended lectures from each course have been picked out. This recommendations help you discover more of the lectures you are interested in.

    • 0:27:38

      Cancer Biology and Molecular Biology

      This content is going to discuss a lecture titled “Cancer Biology and Molecular Biology” for the Cancer Genome-based Medicine Course as part of the presentation series in the ATLAS Training Program.

      Views160

      User evaluation4.48

      Updated on：30 Nov 2021

    • 0:20:50

      Sample handling

      1. Sample Handling Process in Cancer Genomic Medicine2. Tumor Sample Evaluation Procedure3. Examples of Tumor Evaluation4. Tumor Sample Evaluation (Tumor Cell Content)

      Views59

      User evaluation4.35

      Updated on：29 Jun 2021

    • 0:18:06

      Procedures and Interpretation of Next Generation Sequencing Results

      1. Characteristics of gene panel tests and interpretation of the results2. Pathogenic significance of detected mutations3. Mutations and associated therapeutic agents4. Candidate drugs and their evidence levels

      Views45

      User evaluation4.22

      Updated on：9 Jul 2021

    • 0:18:25

      Methods of utilizing NGS test results (off-label, clinical trial, etc.)

      Information on the topics listed on this slide will be presented in the lecture.・Cancer genomic medicine and comprehensive genomic profiling (CGP) test・Treatment based on cancer genomic profiling

      Views63

      User evaluation4.33

      Updated on：12 Dec 2022

    • 0:34:37

      ISO 15189 accreditation program for molecular-genetic laboratories

      1. Efforts for quality assurance in molecular-genetic testing2. Implementation guidance of ISO 15189 for NGS-based tests3. Regional and international efforts to standardize the pre-examination process4. International efforts to standardize multiplex molecular-genetic tests5. Challenges to the EQA/PT program

      Views20

      User evaluation0.00

      Updated on：2 Jun 2021

    • 0:26:04

      Basic Knowledge and Practical Consideration of Phase I Trials in Oncology

      Information on the topics listed on this slide will be presented in the lecture.1. First administration of novel anticancer drugs in human.2. Determining the optimal dose and administration method.3. Dose escalation test using toxicity as an index.

      Views43

      User evaluation4.50

      Updated on：27 Mar 2023

    • 0:40:03

      The General Role Of CRCs In Cancer Clinical Trials

      1. Role of CRC in Cancer Clinical Trials2. Provide Support to Subjects Participating in Cancer Clinical Trials3. Support for conducting Cancer Clinical Trials

      Views44

      User evaluation4.39

      Updated on：23 May 2022

    • 0:28:53

      Review of cancer clinical trial protocols from a CRC perspective

      1. Role and definition of the protocol2. Perspective of CRC reading of the protocol3. Uncomfortable situations when conducting clinical trials4. Summary

      Views37

      User evaluation4.29

      Updated on：24 May 2022

    • 0:18:37

      Minimum statistical knowledge required for clinical trials on cancer - Part 1 of 2

      Some key points for interpreting the results of phase III randomized controlled trials are introduced in this lecture. Particularly, this part outlines survival curve and randomization.

      Views26

      User evaluation4.67

      Updated on：20 Sep 2023

    • 0:31:42

      Designs for clinical trials on cancer - Part 1 of 2

      Development flow and clinical trial designs of anticancer drugs are introduced in this lecture. Particularly, this part outlines development flow and phase I clinical trial designs.

      Views12

      User evaluation4.33

      Updated on：20 Sep 2023
    ‹
    ›

Introduction to Clinical Research

  • Top Page
  • What is ICRweb
  • Regulatory Guidelines
  • FAQ
  • Contact Us

Course List

Course List
  • Cancer Genomic Medicine: Essential Course
  • Cancer Genomic Medicine: the Practice in Japan
  • ISO 15189 Accreditation Support Course
  • Phase 1 Trial Development Course
  • CRC Training Course
  • Outline of Clinical Trials on Cancer
  • ATLAS International Symposium
  • SICRES seminar
  • ATLAS Monthly Webinar
  • Site Policy

Copyright © 2007-2024 ICRweb all rights reserved.